New hope for Late-Stage breast cancer: experimental combo targets tumors when other options fail
Disease control
Recruiting now
This study tests whether a new treatment called Bria-IMT, given with an immunotherapy drug, helps people with advanced metastatic breast cancer live longer compared to standard chemotherapy. It is for patients whose cancer has not responded to available treatments. About 404 adul…
Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated May 06, 2026 16:01 UTC